IL-12 administration reveals diabetogenic T cells in genetically resistant I-Eα-transgenic nonobese diabetic mice: Resistance to autoimmune diabetes is associated with binding of Eα-derived peptides to the I-Ag7 molecule

Journal of Immunology

Volumn 167, Issue 7, 2001, Pages 4104-4114

  Trembleau, S ^a   Gregori, S ^a   Penna, G ^a   Gorny, I ^a   Adorini, L ^a  

^a ROCHE MILANO RICERCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; PEPTIDE;

ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BINDING AFFINITY; CELL PROTECTION; COMPLEX FORMATION; DIABETES MELLITUS; DIABETOGENESIS; GENE EXPRESSION REGULATION; GENETIC RESISTANCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENIC MOUSE;

EID: 0035478325     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.7.4104     Document Type: Article

References (64)

1. The NOD mouse model of type 1 diabetes: As good as it gets?
2. Genetic control of autoimmune diabetes in the NOD mouse
3. The NOD mouse: Recessive diabetogenic gene in the major histocompatibility complex
4. The first external domain of the non obese diabetic mouse class II I-A β chain is unique
5. Non-obese diabetic and non obese non-diabetic mice have unique MHC class II haplotypes
6. The murine autoimmune diabetes model: NOD and related strains
7. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice
8. k NOD transgenic mice
9. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chain
10. MHC-linked protection from diabetes dissociated from clonal deletion of T cells
11. Complete prevention of diabetes in transgenic NOD mice expressing I-E molecules
12. + T cells
13. Class I and class II MHC gene products differentially affect the fate of Vβ5 bearing thymocytes
14. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes
15. The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes
16. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity
17. + thymocytes by protective MHC class II molecules
18. A unified hypothesis for the complex genetics of HLA associations with IDDM
19. Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease
20. Dominant disease protection in MHC-transgenic NOD mice: More than one mechanism?
21. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection
22. The murine Eα immune response gene
23. Transgenic HLA-DRα faithfully reconstitutes I-E controlled immune functions and induces cross-tolerance to Eα in Eα° mutant mice
24. NOD molecule on the development of insulitis and diabetes in the non-obese diabetic (NOD) mouse
25. IL-12 administration induces Th1 cells and accelerates autoimmune diabetes in NOD mice
26. DRα:Eβ heterodimers in DRA transgenic mice hinder expression of Eα:Eβ molecules and are more efficient in antigen presentation
27. Tissue specific expression of the HLA-DRA gene in transgenic mice
28. Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo
29. Expression of PTP35, the murine homologue of the protein tyrosine phosphatase-related sequence IA-2, is regulated during cell growth and stimulated by mitogens in 3T3 fibroblasts
30. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes
31. g7, the class II MHC molecule of NOD and Biozzi AB/H mice
32. g7, the class II molecule that protects Eα-transgenic nonobese diabetic mice from autoimmune diabetes
33. Heterogeneity of intracellular cytokine synthesis at the singlecell level in polarized T helper 1 and T helper 2 populations
34. Mechanisms influencing the immunodominance of T cell determinants
35. MHC molecular mimicry in diabetes
36. A self MHC class II β-chain peptide prevents diabetes in nonobese diabetic mice
37. Prevention of systemic lupus erythematosus in autoimmune BXSB mice by a transgene encoding I-E α chain
38. b molecules
39. Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant
40. Dendritic cells are the most efficient in presenting endogenous naturally processed self epitopes to class-II restricted T cells
41. g7 and autoimmune diabetes
42. Three-dimensional structure of the human class II histocompatibility antigen HLA-DRI
43. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes
44. Regulation of the IL-12 receptor β2 subunit by soluble antigen and IL-12 in vivo
45. Dominance and crypticity of the cell antigenic determinants
46. A novel MHC class II epitope expressed in thymic medulla but not cortex
47. Presentation and intercellular transfer of self antigen within the thymic microenvironment: Expression of the Eα peptide I-Ab complex by isolated thymic stroma cells
48. Multiple levels of peripheral tolerance
49. In vivo competition between self peptides and foreign antigens in T-cell activation
50. Prevention of autoimmune diabetes in non-obese diabetic mice by treatment with a class II major histocompatibility complex-blocking peptide
51. Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis
52. Inhibition of cell cycle progression by a synthetic peptide corresponding to residues 65-79 of an HLA class II sequence: Functional similarities by mechanistic differences with the immunosuppressive drug rapamycin
53. Molecular basis for recognition of an arthritic peptide and a foreign epitope on distinct MHC molecules by a single TCR
54. Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice: The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes
55. Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice
56. k transgenic mice
57. d transgene prevents diabetes in nonobese diabetic mice by inducing regulatory T cells
58. g7 β-chain diminishes the spontaneous incidence of insulin-dependent diabetes mellitus
59. + nonobese diabetic mice develop insulitis and diabetes
60. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes
61. 2
62. Prevention of diabetes in NOD mice by a mutated I-Ab transgene
63. Th1 to Th2 cytokine shifts in nonobese diabetic mice: Sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation
64. Exacerbated autoimmunity associated with a T helper-1 cytokine profile shift in H-2E-transgenic mice